Morgan Stanley’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $22.5K | Sell |
20,100
-14,404
| -42% | -$16.1K | ﹤0.01% | 6618 |
|
2025
Q1 | $39.7K | Sell |
34,504
-62,413
| -64% | -$71.8K | ﹤0.01% | 6350 |
|
2024
Q4 | $592K | Sell |
96,917
-742
| -0.8% | -$4.53K | ﹤0.01% | 5351 |
|
2024
Q3 | $1.62M | Sell |
97,659
-13,852
| -12% | -$229K | ﹤0.01% | 4770 |
|
2024
Q2 | $766K | Buy |
111,511
+10,416
| +10% | +$71.6K | ﹤0.01% | 5113 |
|
2024
Q1 | $976K | Sell |
101,095
-88,987
| -47% | -$859K | ﹤0.01% | 4966 |
|
2023
Q4 | $1.58M | Buy |
190,082
+116,288
| +158% | +$966K | ﹤0.01% | 5062 |
|
2023
Q3 | $616K | Sell |
73,794
-26,142
| -26% | -$218K | ﹤0.01% | 5073 |
|
2023
Q2 | $922K | Buy |
99,936
+18,252
| +22% | +$168K | ﹤0.01% | 4880 |
|
2023
Q1 | $1.12M | Sell |
81,684
-10,053
| -11% | -$138K | ﹤0.01% | 4795 |
|
2022
Q4 | $1.56M | Sell |
91,737
-8,256
| -8% | -$140K | ﹤0.01% | 4611 |
|
2022
Q3 | $2.27M | Sell |
99,993
-25,149
| -20% | -$572K | ﹤0.01% | 4334 |
|
2022
Q2 | $2.26M | Buy |
125,142
+28,552
| +30% | +$514K | ﹤0.01% | 4437 |
|
2022
Q1 | $2.58M | Buy |
96,590
+45,611
| +89% | +$1.22M | ﹤0.01% | 4326 |
|
2021
Q4 | $1.5M | Buy |
50,979
+5,561
| +12% | +$163K | ﹤0.01% | 4788 |
|
2021
Q3 | $2.99M | Buy |
45,418
+352
| +0.8% | +$23.2K | ﹤0.01% | 4237 |
|
2021
Q2 | $3.75M | Buy |
45,066
+2,345
| +5% | +$195K | ﹤0.01% | 4083 |
|
2021
Q1 | $3.28M | Buy |
42,721
+10,958
| +34% | +$841K | ﹤0.01% | 3846 |
|
2020
Q4 | $2.8M | Buy |
31,763
+29,217
| +1,148% | +$2.58M | ﹤0.01% | 3859 |
|
2020
Q3 | $188K | Sell |
2,546
-5,115
| -67% | -$378K | ﹤0.01% | 5150 |
|
2020
Q2 | $559K | Buy |
7,661
+3,703
| +94% | +$270K | ﹤0.01% | 4542 |
|
2020
Q1 | $223K | Sell |
3,958
-3,812
| -49% | -$215K | ﹤0.01% | 4817 |
|
2019
Q4 | $297K | Buy |
7,770
+7,001
| +910% | +$268K | ﹤0.01% | 5226 |
|
2019
Q3 | $14K | Buy |
+769
| New | +$14K | ﹤0.01% | 6110 |
|